Investment Summary |
|
|---|---|
| Date | 2011-04-01 |
| Target | Tranzyme |
| Sector | Life Science |
| Sellers(s) | Greer Capital Advisors |
| Deal Type | IPO |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2002 |
| Size | Small |
| Type | Sector Focused |
Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 13 |
| Sector (Life Science) | 5 of 10 |
| Type (IPO) | 2 of 2 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 7 of 13 |
| Year (2011) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-12-23 |
Atherotech
Birmingham, Alabama, United States Atherotech, Inc. is a cardio-diagnostic company. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-04-04 |
TransMolecular
Cambridge, Massachusetts, United States TransMolecular is a neuroscience therapeutics company discovering and developing novel, proprietary drugs to diagnose and treat cancer and pain. |
Sell | - |
